miR‑199a‑3p is involved in the pathogenesis and progression of diabetic neuropathy through downregulation of SerpinE2

Li,Ying‑Bo; Wu,Qun; Liu,Jie; Fan,Yong‑Zhi; Yu,Kai‑Feng; Cai,Yi

doi:10.3892/mmr.2017.6874

miR‑199a‑3p is involved in the pathogenesis and progression of diabetic neuropathy through downregulation of SerpinE2

Authors:
- Ying‑Bo Li
- Qun Wu
- Jie Liu
- Yong‑Zhi Fan
- Kai‑Feng Yu
- Yi Cai
View Affiliations

Affiliations: Department of Pain Management, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430014, P.R. China, Department of Pathology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430014, P.R. China, Department of Anesthesiology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430014, P.R. China
Published online on: June 28, 2017 https://doi.org/10.3892/mmr.2017.6874
Pages: 2417-2424
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the expression status of miRNA‑199a‑3p in patients with diabetic neuropathy (DN) and the mechanism by which this miRNA is involved in the genesis of DN. The expression of miRNA‑199a‑3p in plasma of peripheral blood was compared between patients with diabetes and a family history of diabetes and control volunteers by reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR); in 60 diabetes patients, 45 (75%) demosntrated upregulated miR‑199a‑3p expression compared with control volunteer plasma. RT‑qPCR was also used to detect miRNA‑199a‑3p expression in paired lower limb skin tissues from 30 patients with DN and 20 control volunteers; miR‑199a‑3p expression in patients with DN was significantly higher than in the control group. Next miR‑199a‑3p expression levels were evaluated with respect to the clinic‑pathological parameters of diabetes; increased expression of miR‑199a‑3p was significantly associated with increased disease duration (P=0.041), glycated hemoglobin (HbA1C) levels (P=0.033), and fibrinogen levels (P=0.003). Finally, the effects on downstream mRNA expression levels were investigated as a result of manipulating miR‑199a‑3p levels. miR‑199a‑3p overexpression inhibited the expression of the extracellular serine protease inhibitor E2 (SerpinE2). Therefore, it may be hypothesized that miR‑199a‑3p can induce DN via promoting coagulation in skin peripheral circulation, through the downregulation of SerpinE2. The present findings suggested that miR‑199a‑3p may have potential as a novel therapeutic target for the treatment of patients with DN.

View Figures

View References

1	Shi TJ, Zhang MD, Zeberg H, Nilsson J, Grünler J, Liu SX, Xiang Q, Persson J, Fried KJ, Catrina SB, et al: Coenzyme Q10 prevents peripheral neuropathy and attenuates neuron loss in the db-/db- mouse, a type 2 diabetes model. Proc Natl Acad Sci USA. 110:690–695. 2013. View Article : Google Scholar : PubMed/NCBI
2	Haw JS, Tantry S, Vellanki P and Pasquel FJ: National strategies to decrease the burden of diabetes and its complications. Curr Diab Rep. 15:652015. View Article : Google Scholar : PubMed/NCBI
3	Palmer BF and Clegg DJ: Electrolyte and acid-base disturbances in patients with diabetes mellitus. N Engl J Med. 373:548–559. 2015. View Article : Google Scholar : PubMed/NCBI
4	Bouton MC, Boulaftali Y, Richard B, Arocas V, Michel JB and Jandrot-Perrus M: Emerging role of serpinE2/protease nexin-1 in hemostasis and vascular biology. Blood. 119:2452–2457. 2012. View Article : Google Scholar : PubMed/NCBI
5	Valiente M, Obenauf AC, Jin X, Chen Q, Zhang XH, Lee DJ, Chaft JE, Kris MG, Huse JT, Brogi E and Massagué J: Serpins promote cancer cell survival and vascular co-option in brain metastasis. Cell. 156:1002–1016. 2014. View Article : Google Scholar : PubMed/NCBI
6	Santoro A, Conde J, Scotece M, Abella V, Lois A, Lopez V, Pino J, Gomez R, Gomez-Reino JJ and Gualillo O: SERPINE2 inhibits IL-1α-induced MMP-13 expression in human chondrocytes: Involvement of ERK/NF-κB/AP-1 pathways. PLoS One. 10:e01359792015. View Article : Google Scholar : PubMed/NCBI
7	Alsaweed M, Lai CT, Hartmann PE, Geddes DT and Kakulas F: Human milk miRNAs primarily originate from the mammary gland resulting in unique miRNA profiles of fractionated milk. Sci Rep. 6:206802016. View Article : Google Scholar : PubMed/NCBI
8	Yuan Y, Kang R, Yu Y, Liu J, Zhang Y, Shen C, Wang J, Wu P, Shen C and Wang Z: Crosstalk between miRNAs and their regulated genes network in stroke. Sci Rep. 6:204292016. View Article : Google Scholar : PubMed/NCBI
9	Inui M, Martello G and Piccolo S: MicroRNA control of signal transduction. Nat Rev Mol Cell Biol. 11:252–263. 2010. View Article : Google Scholar : PubMed/NCBI
10	Hur K, Toiyama Y, Okugawa Y, Ide S, Imaoka H, Boland CR and Goel A: Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer. Gut. 66:654–665. 2017. View Article : Google Scholar : PubMed/NCBI
11	Liu FY, Zhou SJ, Deng YL, Zhang ZY, Zhang EL, Wu ZB, Huang ZY and Chen XP: MiR-216b is involved in pathogenesis and progression of hepatocellular carcinoma through HBx-miR-216b-IGF2BP2 signaling pathway. Cell Death Dis. 6:e16702015. View Article : Google Scholar : PubMed/NCBI
12	Liu FY, Deng YL, Li Y, Zeng D, Zhou ZZ, Tian DA and Liu M: Down-regulated KLF17 expression is associated with tumor invasion and poor prognosis in hepatocellular carcinoma. Med Oncol. 30:4252013. View Article : Google Scholar : PubMed/NCBI
13	Wang X, Li W, Ma L, Gao J, Liu J, Ping F and Nie M: Association study of the miRNA-binding site polymorphisms of CDKN2A/B genes with gestational diabetes mellitus susceptibility. Acta Diabetol. 52:951–958. 2015. View Article : Google Scholar : PubMed/NCBI
14	Chen Y, Wang X and Shao X: A combination of human embryonic stem cell-derived pancreatic endoderm transplant with LDHA-repressing miRNA can attenuate high-fat diet induced type II diabetes in mice. J Diabetes Res. 2015:7969122015. View Article : Google Scholar : PubMed/NCBI
15	Song C, Ji Y, Zou G and Wan C: Tetrandrine down-regulates expression of miRNA-155 to inhibit signal-induced NF-κB activation in a rat model of diabetes mellitus. Int J Clin Exp Med. 8:4024–4030. 2015.PubMed/NCBI
16	Chattopadhyay M, Zhou Z, Hao S, Mata M and Fink DJ: Reduction of voltage gated sodium channel protein in DRG by vector mediated miRNA reduces pain in rats with painful diabetic neuropathy. Mol Pain. 8:172012. View Article : Google Scholar : PubMed/NCBI
17	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-(Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
18	Nam JW, Rissland OS, Koppstein D, Abreu-Goodger C, Jan CH, Agarwal V, Yildirim MA, Rodriguez A and Bartel DP: Global analyses of the effect of different cellular contexts on microRNA targeting. Mol Cell. 53:1031–1043. 2014. View Article : Google Scholar : PubMed/NCBI
19	Kozomara A and Griffiths-Jones S: miRBase: Annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 42:(Database Issue). D68–D73. 2014. View Article : Google Scholar : PubMed/NCBI
20	Kozomara A and Griffiths-Jones S: miRBase: Integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 39:(Database Issue). D152–D157. 2011. View Article : Google Scholar : PubMed/NCBI
21	Griffiths-Jones S, Saini HK, van Dongen S and Enright AJ: miRBase: Tools for microRNA genomics. Nucleic Acids Res. 36:(Database Issue). D154–D158. 2008. View Article : Google Scholar : PubMed/NCBI
22	Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A and Enright AJ: miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 34:(Database issue). D140–D144. 2006. View Article : Google Scholar : PubMed/NCBI
23	Griffiths-Jones S: The microRNA registry: Nucleic Acids Res. 32:(Database issue). D109–D111. 2004.
24	Tornovsky-Babeay S, Dadon D, Ziv O, Tzipilevich E, Kadosh T, Haroush R Schyr-Ben, Hija A, Stolovich-Rain M, Furth-Lavi J, Granot Z, et al: Type 2 diabetes and congenital hyperinsulinism cause DNA double-strand breaks and p53 activity in beta cells. Cell Metab. 19:109–121. 2014. View Article : Google Scholar : PubMed/NCBI
25	Chen BF, Suen YK, Gu S, Li L and Chan WY: A miR-199a/miR-214 self-regulatory network via PSMD10, TP53 and DNMT1 in testicular germ cell tumor. Sci Rep. 4:64132014. View Article : Google Scholar : PubMed/NCBI
26	Seviour EG, Sehgal V, Lu Y, Luo Z, Moss T, Zhang F, Hill SM, Liu W, Maiti SN, Cooper L, et al: Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer. Oncogene. 35:8012016. View Article : Google Scholar : PubMed/NCBI
27	Thomas H: Diabetes: Enterovirus dysregulates islet miRNAs. Nat Rev Endocrinol. 12:22016. View Article : Google Scholar
28	Jansen F, Wang H, Przybilla D, Franklin BS, Dolf A, Pfeifer P, Schmitz T, Flender A, Endl E, Nickenig G and Werner N: Vascular endothelial microparticles-incorporated microRNAs are altered in patients with diabetes mellitus. Cardiovasc Diabetol. 15:492016. View Article : Google Scholar : PubMed/NCBI
29	Kornfeld JW, Baitzel C, Könner AC, Nicholls HT, Vogt MC, Herrmanns K, Scheja L, Haumaitre C, Wolf AM and Knippschild U: Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b. Nature. 494:111–115. 2013. View Article : Google Scholar : PubMed/NCBI
30	Yousefzadeh N, Alipour MR and Soufi FG: Deregulation of NF-кB-miR-146a negative feedback loop may be involved in the pathogenesis of diabetic neuropathy. J Physiol Biochem. 71:51–58. 2015. View Article : Google Scholar : PubMed/NCBI
31	Pencheva N, Tran H, Buss C, Huh D, Drobnjak M, Busam K and Tavazoie SF: Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis. Cell. 151:1068–1082. 2012. View Article : Google Scholar : PubMed/NCBI
32	Lee CG, Kim YW, Kim EH, Meng Z, Huang W, Hwang SJ and Kim SG: Farnesoid X receptor protects hepatocytes from injury by repressing miR-199a-3p, which increases levels of LKB1. Gastroenterology. 142:1206–17.e7. 2012. View Article : Google Scholar : PubMed/NCBI
33	Alemdehy MF, Haanstra JR, de Looper HW, van Strien PM, Verhagen-Oldenampsen J, Caljouw Y, Sanders MA, Hoogenboezem R, de Ru AH, Janssen GM, et al: ICL-induced miR139-3p and miR199a-3p have opposite roles in hematopoietic cell expansion and leukemic transformation. Blood. 125:3937–3948. 2015. View Article : Google Scholar : PubMed/NCBI
34	Omouendze PL, Henry VJ, Porte B, Dupré N, Carmeliet P, Gonzalez BJ, Marret S and Leroux P: Hypoxia-ischemia or excitotoxin-induced tissue plasminogen activator- dependent gelatinase activation in mice neonate brain microvessels. PLoS One. 8:e712632013. View Article : Google Scholar : PubMed/NCBI
35	Garibaldi F, Falcone E, Trisciuoglio D, Colombo T, Lisek K, Walerych D, Del Sal G, Paci P, Bossi G, Piaggio G and Gurtner A: Mutant p53 inhibits miRNA biogenesis by interfering with the microprocessor complex. Oncogene. 35:3760–3770. 2016. View Article : Google Scholar : PubMed/NCBI
36	Morimoto Y, Bando YK, Shigeta T, Monji A and Murohara T: Atorvastatin prevents ischemic limb loss in type 2 diabetes: Role of p53. J Atheroscler Thromb. 18:200–208. 2011. View Article : Google Scholar : PubMed/NCBI